By geography , North America is projected to hold a large share in the Stroke Diagnostics and Therapeutics Industry . The key factors that attribute to the growth of this region include increasing demand , well developed healthcare infrastructure & facilities , technological innovations and growing awareness among people .
On the other hand , Asia Pacific is expected to show fast growth rates in the Stroke Diagnostics and Therapeutics Market . Some of the key players that fuel the growth of the market include Abbott Laboratories , Boston Scientific Corporation , Genentech , Koninklijke Philips N . V , Medtronic plc , Cordis Corporation , Siemens AG , Merck & Co . Inc ., GE Healthcare , Stryker Corporation , and others . The key players are focusing on inorganic growth to sustain themselves amidst fierce competition . As such , mergers , acquisitions , and joint ventures are the need of the hour .
See More Reports of this Category by Million Insights @ https :// www . millioninsights . com / industry / therapeutic-area
Market Segment :
Geographically , this report is segmented into several key Regions , with production , consumption , revenue ( million USD ), market share and growth rate of Stroke Diagnostics and Therapeutics in these regions , from 2012 to 2022 ( forecast ), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India
Global Stroke Diagnostics and Therapeutics market competition by top manufacturers , with production , price , revenue ( value ) and market share for each manufacturer ; the top players including